Shaw Christi 4
4 · Kyverna Therapeutics, Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
Shaw Christi
DirectorExecutive Chairperson
Transactions
- Award
Stock Option (right to buy)
2024-09-16+66,592→ 66,592 totalExercise: $6.89Exp: 2034-09-16→ Common Stock (66,592 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option shall vest on each monthly anniversary, such that 100% of the shares subject to the option shall be fully vested and exercisable on the third anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.